XLRN

Acceleron Pharma Inc.
XLRN

Overview Fund Activity
Delisted

XLRN was delisted on the 19th of November, 2021.

Back to rankings

149 hedge funds and large institutions have $1.47B invested in Acceleron Pharma Inc. in 2017 Q3 according to their latest regulatory filings, with 32 funds opening new positions, 55 increasing their positions, 35 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
149
Holders Change
+21
Holders Change %
+16.41%
% of All Funds
3.72%
Holding in Top 10
6
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+100%
% of All Funds
0.15%
New
32
Increased
55
Reduced
35
Closed
10
Calls
$2.48M
Puts
$11.5M
Net Calls
-$9.06M
Net Calls Change
-$3.61M

Top Buyers

1
FCM
1
Farallon Capital Management
California
$35.9M
2
PA
2
Perceptive Advisors
New York
$60.3M
3
Citigroup
3
Citigroup
New York
$32M
4
DM
4
Deerfield Management
New York
$23M
5
Deutsche Bank
5
Deutsche Bank
Germany
$34.6M

Top Sellers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$139M
2
T. Rowe Price Associates
2
T. Rowe Price Associates
Maryland
$118M
3
GPP
3
Great Point Partners
Connecticut
$6.34M
4
Millennium Management
4
Millennium Management
New York
$13.4M
5
Westfield Capital Management
5
Westfield Capital Management
Massachusetts
$57.5M
Name Holding Trade Value Shares
Change 		Shares
Change %
HP
151
Harbourvest Partners
Massachusetts
– -$1.56M -51,296 Closed
SFM
152
Sphera Funds Management
Israel
– -$1.06M -35,000 Closed
GT
153
Glenmede Trust
Pennsylvania
– -$349K -13,186 Closed
Creative Planning
154
Creative Planning
Kansas
– -$79K -2,597 Closed
DADC
155
D.A. Davidson & Co
Montana
– -$56K -1,861 Closed
OAM
156
Oppenheimer Asset Management
New York
– -$25K -837 Closed
TDC
157
Thompson Davis & Co
Virginia
– -$15K -499 Closed
FC
158
Ferris Capital
Massachusetts
– -$1K -29 Closed
AP
159
AlpInvest Partners
Netherlands
– -$243K – –
3 4 5 6
7